The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial

Willeke F Westendorp, Jan-Dirk Vermeij, Elles Zock, Imke J Hooijenga, Nyika D Kruyt, Hans J L W Bosboom, Vincent I H Kwa, Martijn Weisfelt, Michel J M Remmers, Robert ten Houten, A H C M (Tobien) Schreuder, Sarah E Vermeer, Ewout J van Dijk, Diederik W J Dippel, Marcel G W Dijkgraaf, Lodewijk Spanjaard, Marinus Vermeulen, Tom van der Poll, Jan M Prins, Frederique H Vermeij, Yvo B W E M Roos, Ruud P Kleyweg, Henk Kerkhoff, Matthijs C Brouwer, Aeilko H Zwinderman, Diederik van de Beek, Paul J Nederkoorn

Open source

DOI
10.1016/s0140-6736(14)62456-9
Published
2015-04
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-14-62456-9,
  title = {The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial},
  author = {Willeke F Westendorp and Jan-Dirk Vermeij and Elles Zock and Imke J Hooijenga and Nyika D Kruyt and Hans J L W Bosboom and Vincent I H Kwa and Martijn Weisfelt and Michel J M Remmers and Robert ten Houten and A H C M (Tobien) Schreuder and Sarah E Vermeer and Ewout J van Dijk and Diederik W J Dippel and Marcel G W Dijkgraaf and Lodewijk Spanjaard and Marinus Vermeulen and Tom van der Poll and Jan M Prins and Frederique H Vermeij and Yvo B W E M Roos and Ruud P Kleyweg and Henk Kerkhoff and Matthijs C Brouwer and Aeilko H Zwinderman and Diederik van de Beek and Paul J Nederkoorn},
  year = {2015},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(14)62456-9},
  url = {https://doi.org/10.1016/s0140-6736(14)62456-9}
}

RIS

TY  - JOUR
TI  - The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial
AU  - Willeke F Westendorp
AU  - Jan-Dirk Vermeij
AU  - Elles Zock
AU  - Imke J Hooijenga
AU  - Nyika D Kruyt
AU  - Hans J L W Bosboom
AU  - Vincent I H Kwa
AU  - Martijn Weisfelt
AU  - Michel J M Remmers
AU  - Robert ten Houten
AU  - A H C M (Tobien) Schreuder
AU  - Sarah E Vermeer
AU  - Ewout J van Dijk
AU  - Diederik W J Dippel
AU  - Marcel G W Dijkgraaf
AU  - Lodewijk Spanjaard
AU  - Marinus Vermeulen
AU  - Tom van der Poll
AU  - Jan M Prins
AU  - Frederique H Vermeij
AU  - Yvo B W E M Roos
AU  - Ruud P Kleyweg
AU  - Henk Kerkhoff
AU  - Matthijs C Brouwer
AU  - Aeilko H Zwinderman
AU  - Diederik van de Beek
AU  - Paul J Nederkoorn
PY  - 2015
JO  - The Lancet
DO  - 10.1016/s0140-6736(14)62456-9
UR  - https://doi.org/10.1016/s0140-6736(14)62456-9
ER  - 

APA

Westendorp, W. F., Vermeij, J., Zock, E., Hooijenga, I. J., Kruyt, N. D., Bosboom, H. J. L. W., Kwa, V. I. H., Weisfelt, M., Remmers, M. J. M., Houten, R. T., Schreuder, A. H. C. M. (., Vermeer, S. E., Dijk, E. J. V., Dippel, D. W. J., Dijkgraaf, M. G. W., Spanjaard, L., Vermeulen, M., Poll, T. V. D., Prins, J. M., Vermeij, F. H., Roos, Y. B. W. E. M., Kleyweg, R. P., Kerkhoff, H., Brouwer, M. C., Zwinderman, A. H., Beek, D. V. D., & Nederkoorn, P. J. (2015). The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. The Lancet. https://doi.org/10.1016/s0140-6736(14)62456-9

Source records